InvestorsHub Logo
Followers 88
Posts 1168
Boards Moderated 0
Alias Born 09/10/2017

Re: kabunushi post# 315196

Thursday, 10/08/2020 1:09:46 AM

Thursday, October 08, 2020 1:09:46 AM

Post# of 701421
right kabunushi, we don’t know the details of the Advent services agreement. I posted that to show that the SOW’s for “activities related to the development of the Sawston facility and the compassionate use activities in the UK,” was not completed as expected by July, and it was actually extended on August 7th for an additional 12 months. That tells me that although there is a mid October completion date for phase 1 at Sawston, the facility will not be ready for manufacturing until well into next year. You’re probably aware that there were additional disclosures in the 10-Q that no compassionate use manufacturing occurred during Q2 due to lockdowns, travel restrictions, and personnel under lockdown, and this could be halted again if they’ve been restarted during Q3 and Q4. I suspect that the cell characterization and optimization work that needs to be done to produce DCVax on the MicroDEN system can’t be started until the phase 1 construction has been completed, but Advent personnel may have to prioritize the backlog of compassionate use cases over this work. What do you think?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News